<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: AstraZeneca Investor Questions Big Pharma Model</title>
	<atom:link href="http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Thu, 18 Mar 2010 13:37:42 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Mark&#8217;s Daily Apple &#187; Blog Archive &#187; We Like Drugs - Fair and Balanced</title>
		<link>http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/#comment-287993</link>
		<dc:creator>Mark&#8217;s Daily Apple &#187; Blog Archive &#187; We Like Drugs - Fair and Balanced</dc:creator>
		<pubDate>Wed, 16 Apr 2008 16:31:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/#comment-287993</guid>
		<description>[...] Pharmalot: AstraZeneca Investor Questions Big Pharma Model [...]</description>
		<content:encoded><![CDATA[<p>[...] Pharmalot: AstraZeneca Investor Questions Big Pharma Model [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: AstraZeneca Investor Questions Big Pharma Model &#124; Pharma Night Fever</title>
		<link>http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/#comment-262696</link>
		<dc:creator>AstraZeneca Investor Questions Big Pharma Model &#124; Pharma Night Fever</dc:creator>
		<pubDate>Tue, 08 Apr 2008 10:05:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/#comment-262696</guid>
		<description>[...] Anonymous reuters.interactive@reuters.com wrote an interesting post today onHere&#8217;s a quick excerptOne of the biggest shareholders in AstraZeneca is questioning the long-term viability of the ‘Big Pharma’ business model by asking whether it could discourage the development of new meds, The Times of London writes. &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] Anonymous <a href="mailto:reuters.interactive@reuters.com">reuters.interactive@reuters.com</a> wrote an interesting post today onHere&#8217;s a quick excerptOne of the biggest shareholders in AstraZeneca is questioning the long-term viability of the ‘Big Pharma’ business model by asking whether it could discourage the development of new meds, The Times of London writes. &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: ol cranky</title>
		<link>http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/#comment-260132</link>
		<dc:creator>ol cranky</dc:creator>
		<pubDate>Mon, 07 Apr 2008 23:36:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/04/astrazeneca-investor-questions-big-pharma-model/#comment-260132</guid>
		<description>Ekholm knows as well as the big pharma execs that the big pharma model is not good for anyone and certainly doesn't help drug development</description>
		<content:encoded><![CDATA[<p>Ekholm knows as well as the big pharma execs that the big pharma model is not good for anyone and certainly doesn&#8217;t help drug development</p>
]]></content:encoded>
	</item>
</channel>
</rss>
